Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

New approach to quantify cognitive decline in dogs could aid in the treatment of humans with Alzheimer’s

Researchers have found that a suite of complementary tests can quantify changes in dogs suspected of suffering from cognitive decline.

30 May 2022

Study evaluates diagnostic performance of two blood-based biomarkers specific to Alzheimer's disease

A simple blood test to diagnose Alzheimer's disease, perhaps even years before symptoms appear, is an exciting possibility, but a new study shows that much more research is needed before these blood tests are routinely used in the clinical diagnostic setting.

26 May 2022

Researchers receive $8 million grant to prevent traumatic brain injury in military personnel

Researchers backed by an $8 million U.S. Department of Defense grant will explore how to better prevent traumatic brain injury, or TBI, in military personnel exposed to blast shock waves.

26 May 2022

Size of air pollution particles may affect a person's risk of dying from stroke, study finds

Living in areas with higher air pollution is associated with an increased risk of in-hospital death from stroke, and the risk varies depending on the size of the air pollution particles, according to a new study published in the May 25, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

25 May 2022

Study uncovers a possible mechanism that links cerebrovascular disease and Alzheimer's

For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer's disease.

25 May 2022

A sugar-studded protein could be key to stopping Alzheimer’s disease progression, finds study

In a bit of "reverse engineering" research using brain tissues from five people who died with Alzheimer's disease, Johns Hopkins Medicine researchers say they discovered that a special sugar molecule could play a key role in the development of Alzheimer's disease.

25 May 2022

Seven healthy habits may lower the risk of dementia in people with high genetic risk

Seven healthy habits and lifestyle factors may play a role in lowering the risk of dementia in people with the highest genetic risk, according to research published in the May 25, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

25 May 2022

Studies find breakthrough SARS-CoV-2 Infections are more likely in cancer and Alzheimer's patients

Breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are significantly more likely in cancer and Alzheimer's patients, according to two new studies from researchers at the Case Western Reserve University School of Medicine.

23 May 2022

Neuroscientists pinpoint brain mechanism responsible for common type of age-related memory loss

Working with rats, neuroscientists at Johns Hopkins University have pinpointed a mechanism in the brain responsible for a common type of age-related memory loss.

20 May 2022

Novel brain-permeable Cdk5 inhibitor alters neurobehavior in mice

James Bibb, Ph.D., and colleagues have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.

20 May 2022

Researchers discover possible connection between harmful amyloid production and COVID-19 symptoms

In patients with serious and long-term COVID-19, disturbed blood coagulation has often been observed. Now, researchers at Linköping University, Sweden, have discovered that the body's immune system can affect the spike protein on the surface of the SARS-CoV-2 virus, leading to the production of a misfolded spike protein called amyloid.

19 May 2022

Study supports the use of age-specific risk prediction scores for dementia

Which vascular risk factors are associated with the risk of developing dementia may vary with age. A new study shows that among people around age 55, the risk of developing dementia over the next 10 years was increased in those with diabetes and high blood pressure.

19 May 2022

Acoustic holograms enable efficient, selective opening of the blood brain barrier

The holograms designed by the team of researchers from UPV and CSIC allow the opening of the blood brain barrier selectively, efficiently and in a highly focused manner, facilitating the administration of therapeutic drugs to treat pathologies that affect the central nervous system.

17 May 2022

UCF researchers developing new tool to help protect the elderly from scammers

UCF researchers are developing a tool for primary care providers that could help them protect senior citizens from scammers who steal everything from the elderly's life's savings to their identity.

13 May 2022

Mitochondrial respiratory chain is essential for NLRP3 inflammasome activation

Northwestern Medicine investigators recently discovered that the mitochondrial respiratory chain — a series of protein complexes essential for a cellular respiration and energy production — is necessary for the activation of another protein complex linked to inflammation and the progression of chronic diseases, according to a study published in Nature Immunology.

12 May 2022

Alzheimer's Disease News and Research

Further Reading

New approach to quantify cognitive decline in dogs could aid in the treatment of humans with Alzheimer’s

Study evaluates diagnostic performance of two blood-based biomarkers specific to Alzheimer's disease

Researchers receive $8 million grant to prevent traumatic brain injury in military personnel

Size of air pollution particles may affect a person's risk of dying from stroke, study finds

Study uncovers a possible mechanism that links cerebrovascular disease and Alzheimer's

A sugar-studded protein could be key to stopping Alzheimer’s disease progression, finds study

Seven healthy habits may lower the risk of dementia in people with high genetic risk

Studies find breakthrough SARS-CoV-2 Infections are more likely in cancer and Alzheimer's patients

Neuroscientists pinpoint brain mechanism responsible for common type of age-related memory loss

Novel brain-permeable Cdk5 inhibitor alters neurobehavior in mice

Researchers discover possible connection between harmful amyloid production and COVID-19 symptoms

Study supports the use of age-specific risk prediction scores for dementia

Acoustic holograms enable efficient, selective opening of the blood brain barrier

UCF researchers developing new tool to help protect the elderly from scammers

Mitochondrial respiratory chain is essential for NLRP3 inflammasome activation

General Internal Medicine and Geriatrics officially separated into two divisions

Discovery of host co-factors necessary for SARS-CoV2 infection

New research reveals a potent weapon against Parkinson's disease

Daily blueberry intake may lower the chances of developing late-life dementia

Maternal antidepressant use during pregnancy does not increase epilepsy risk in babies

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News